Lv5
980 积分 2024-01-17 加入
PARP inhibition enhances the antitumor activity of HER3-DXd in non-small cell lung cancer
2天前
已完结
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study
2天前
已完结
Rare Fusions, Real Targets: Ultraprecision Oncology in Lung Cancer
2天前
已完结
The Basics of Metabolic Dysfunction-Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis, and Treatment
29天前
已完结
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management
1个月前
已完结
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-management
1个月前
已完结
The association of frailty with cardiovascular diseases and mortality in metabolic dysfunction-associated steatotic liver disease
2个月前
已完结
Does the benefit of optimal MASH treatment depend on a reduction in myosteatosis?
2个月前
已完结
The relationship between nonalcoholic fatty liver disease and frailty: A systematic review and meta-analysis
2个月前
已完结
Branched‐chain amino acid metabolism: Pathophysiological mechanism and therapeutic intervention in metabolic diseases
2个月前
已完结
皖公网安备34019202002308
